(Q45367797)

English

Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts

scientific article published on 27 November 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

0 references

Streptococcus gordonii

object named as

Streptococcus gordonii

1 reference

based on heuristic

inferred from title

object named as

Elena Pettini

2

0 references

Donata Medaglini

object named as

Donata Medaglini

5

0 references

object named as

Gianni Pozzi

4

0 references

author name string

Annalisa Ciabattini

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Slavica Arsenijevic

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

27 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1226-1233

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Follicular helper T cells as cognate regulators of B cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Adoptive transfer of transgenic T cells to study mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Compartmentalization within the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Immunologic uniqueness of the genital tract: challenge for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Innate and adaptive immunity in female genital tract: cellular responses and interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Upper Respiratory Tract Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Humoral immune responses to microbial infections in the genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Heterologous prime-boost vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

A host-vector system for heterologous gene expression in Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Determination of lymphocyte division by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Expressionin vivo of CD45RA, CD45RB and CD44 on T cell receptor-transgenic CD8+ T cells following immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Ligands for L-selectin: homing, inflammation, and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

HIV disease: fallout from a mucosal catastrophe?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mucosal T-cell responses to HIV: responding at the front lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Cyclical expression of L-selectin (CD62L) by recirculating T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Lymphocyte trafficking and regional immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.11.021

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45367797&oldid=2075902078"